Advenchen Laboratories, LLC
6 clinical trials · Sponsor
◉ Watch Advenchen Laboratories, LLC
| Record | Firm | Date |
|---|---|---|
| A Study of AL8326 in Non-Small Cell Lung Cancer (NCT06794957) | Advenchen Laboratories, LLC | 2022-05-19 |
| A Phase I/IIa Study of AL8326 Combined With Toripalimab in the Treatment of Advanced Solid Tumors. (NCT07392736) | Advenchen Laboratories, LLC | 2021-10-26 |
Track Advenchen Laboratories, LLC automatically
Every clearance here is in the API, with alerts when new ones post.